We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,671 results
  1. Characterization of hERG K+ channel inhibition by the new class III antiarrhythmic drug cavutilide

    Cavutilide (niferidil, refralon) is a new class III antiarrhythmic drug which effectively terminates persistent atrial fibrillation (AF; 84.6% of...

    Denis V. Abramochkin, Oksana B. Pustovit, ... Tatiana Nesterova in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 15 January 2024
  2. Cell-Based hERG Channel Inhibition Assay in High-Throughput Format

    Human ether-a-go-go-related gene (hERG) channel plays an essential role in the repolarization of the cardiac action potential. Genetic mutations and...
    **ghua Zhao, Menghang **a in High-Throughput Screening Assays in Toxicology
    Protocol 2022
  3. Cardiac hERG K+ Channel as Safety and Pharmacological Target

    The human ether-á-go-go related gene (hERG, KCNH2) encodes the pore-forming subunit of the potassium channel responsible for a fast component of the...
    Shi Su, **glei Sun, ... Yanfang Xu in Pharmacology of Potassium Channels
    Chapter 2021
  4. A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2

    Mutations in hERG (human ether-à-go-go-related gene) potassium channel are closely associated with long QT syndromes. By direct Sanger sequencing, we...

    Kai Gu, Duoduo Qian, ... Minglong Chen in Pflügers Archiv - European Journal of Physiology
    Article 15 January 2021
  5. Systematical Evaluation of the Structure-Cardiotoxicity Relationship of 7-Azaindazole-based PI3K Inhibitors Designed by Bioisosteric Approach

    A growing concern of cardiotoxicity induced by PI3K inhibitors has raised the requirements to evaluate the structure-cardiotoxicity relationship...

    Tianze Wu, Yi Chen, ... Yaming Zhou in Cardiovascular Toxicology
    Article 03 October 2023
  6. Cardiovascular Safety Assessment of New Chemical Entities: Current Perspective and Emerging Technologies

    The origin of cardiovascular (CVS) safety assessment studies was marked with the constitution of ICH guidelines that govern the majority of...
    Chapter 2023
  7. Web Services for the Prediction of ADMET Parameters Relevant to the Design of Neuroprotective Drugs

    The ADMET properties (absorption, distribution, metabolism, excretion, and toxicity) of a compound are key factors in its success as a drug. While...
    Valentin O. Perkin, Grigory V. Antonyan, ... Vladimir A. Palyulin in Computational Modeling of Drugs Against Alzheimer’s Disease
    Protocol 2023
  8. Antipsychotics and risk of QT prolongation: a pharmacovigilance study

    Rationale

    While meta-analyses of clinical trials found that lurasidone and partial dopamine agonists (brexpiprazole and aripiprazole) were the...

    Constance Bordet, Philippe Garcia, ... François Montastruc in Psychopharmacology
    Article 14 December 2022
  9. The grapefruit polyphenol naringenin inhibits multiple cardiac ion channels

    Drinking fresh grapefruit juice is associated with a significant prolongation of the QT segment on the electrocardiogram (ECG) in healthy volunteers....

    Camille Sanson, Rachid Boukaiba, ... G. Andrees Bohme in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 12 April 2022
  10. Zebrafish cardiac repolarization does not functionally depend on the expression of the hERG1b-like transcript

    Zebrafish provide a translational model of human cardiac function. Their similar cardiac electrophysiology enables screening of human cardiac...

    Christine E. Genge, Padmapriya Muralidharan, ... Thomas W. Claydon in Pflügers Archiv - European Journal of Physiology
    Article 07 November 2023
  11. The pyridazine heterocycle in molecular recognition and drug discovery

    The pyridazine ring is endowed with unique physicochemical properties, characterized by weak basicity, a high dipole moment that subtends π-π...

    Nicholas A. Meanwell in Medicinal Chemistry Research
    Article 15 March 2023
  12. The atypic antipsychotic clozapine inhibits multiple cardiac ion channels

    Clozapine is an atypical neuroleptic used to manage treatment-resistant schizophrenia which is known to inhibit cardiac hERG/K V 11.1 potassium...

    Marguerite Le Marois, Camille Sanson, ... G. Andrees Bohme in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 29 October 2022
  13. Unraveling the Pharmaceutical Benefits of Freshly Prepared Amino Acid-Based Schiff Bases Via DFT, In Silico Molecular Docking and ADMET

    A series of amino acid-based Schiff bases have been synthesized using a facile condensation between benzil (a diketone) and amino acid in the...

    Subramanian Ramasamy, Arun Thesingu Rajan in Journal of Fluorescence
    Article 24 June 2022
  14. Artificial Intelligence in Drug Safety and Metabolism

    The use of artificial intelligence methods in drug safety began in the early 2000s with applications such as predicting bacterial mutagenicity and...
    Protocol 2022
  15. Parent and Metabolite Concentration-QT Modeling to Evaluate QT-Interval Prolongation at Savolitinib Therapeutic Doses

    Savolitinib is an oral, potent, and highly selective MET-tyrosine kinase inhibitor under investigation in various tumor types. A thorough QT study...

    Stein Schalkwijk, Tar**der Sahota, ... Ghada F. Ahmed in The AAPS Journal
    Article 17 March 2021
  16. Antimalarial activity assay of artesunate-3-chloro-4(4-chlorophenoxy) aniline in vitro and in mice models

    The global spread of multi-drug resistant P. falciparum , P. vivax , and P. malariae strains and absence of long-term effective vaccine makes...

    Milka Wambui Waithera, Martin Wekesa Sifuna, ... Masahiro Takei in Parasitology Research
    Article 02 March 2023
  17. Therapeutic Targeting of Potassium Channels

    Potassium (K+) channels are the largest group of ion channels in mammals. The immediate function of these channels is electrogenic transport of K+...
    Nikita Gamper, Dongyang Huang, ... Hailin Zhang in Ion Channels as Targets in Drug Discovery
    Chapter 2024
  18. Detection of a novel pathogenic variant in KCNH2 associated with long QT syndrome 2 using whole exome sequencing

    Background

    Long QT syndrome (LQTS) is a cardiac channelopathy characterized by impaired myocardial repolarization that predisposes to life-threatening...

    Erfan Kohansal, Niloofar Naderi, ... Samira Kalayinia in BMC Medical Genomics
    Article Open access 07 May 2024
  19. Opioids-Induced Long QT Syndrome: A Challenge to Cardiac Health

    The challenge posed by opioid overdose has become a significant concern for health systems due to the complexities associated with drug prohibition,...

    Jiale Hu, Yongfei Song, ... Jiangfang Lian in Cardiovascular Toxicology
    Article Open access 17 April 2024
  20. The Short QT Syndrome

    The short QT syndrome (SQTS) is characterised by abbreviated QT intervals on the electrocardiogram and by an increased risk of atrial and ventricular...
    Jules C. Hancox, Mark J. McPate, ... Henggui Zhang in Heart Rate and Rhythm
    Chapter 2023
Did you find what you were looking for? Share feedback.